We report a rare case of moderately differentiated neuroendocrine carcinoma 0/ the larynx. We describe the clinical and pathologicfindings relevant to this case, and we review the literature on the pathologic fe atures ofthis malignancy. We also discuss treatment options.
Fiberoptic laryngoscopy detected a 0.5-cm exophyti c and erythematous mass arising from the left laryngeal surface of the epiglotti s. No cervical lymph adenopathy was evident. Contrast-enhanced fine-cut computed tomography of the larynx and neck failed to identify the small epiglottic lesion or any cervical lymphaden opathy. Findings on chest x-ray were normal.
The patient was taken to the operating room on Sept. 4 for microlaryngoscopy and esophagoscopy. Biopsy specimens of the mass were obtained , and they were later interpreted to represent an infiltrating, moderately differentiated neuroendocrine carcinoma (figure 1). On special staining, chromogranin and CAM 5.2 were strongly positive (figure 2), synaptophysin and neuron-specific enolase were positive, and S-IOO was negative.
The patient was returned to the operating room on Oct. 18, and she underwent a supraglottic laryn gectomy and bilateral anterior neck dissection s ( figure 3 ). The final pathologic analysis identified residual nests of an infiltrating, moder ately differentiated neuroend ocrine carc inoma. There was no infiltrati on of the tumor into the car tilage, and the re were no positiv e nodes on either side of the neck. All surgical margin s were free of tumor. Th e immunohistoc he mica l markers in the surgi cal specimen were identi cal to those in the biopsy speci me n. At followup I year postoperatively, the patie nt was disease-free.
Discussion
Alth ough neuroend ocrin e carci no mas of the larynx are rare, they do account for 59% of all nonsqu amous cancers of the laryn x.' Th ey ca n arise from eit her argyrophilic Kulchitsky ' s ce lls or piuripotenti al saliva ry stem cells.'
Th e three subtypes of neuroend ocrine ca ncers of the larynx are design ated as well different iated,poorly differentiated, and moderately different iated.
Well-differentiated neuroend ocrin e carcinomas (carcinoid tumors) are the rarest of the three (:':::4% of cases). Th ey usually app ear in older men as a suprag lottic mass, and they are associated with hoar seness. Histolo gicall y, these tumors contain uniform sma ll cells with round or ovoi d nucl ei arranged in a trabecul ar pattern.' Electron microscopy reveals abunda nt neurosecretory gra nules . Th ese ca ncers have an indo lent co urse and are effectively treated with surgery .
Poorly differenti ated neuroendocrine carc inomas (sma llce ll or oat-ce ll tum ors) also occur in older men in the suprag lottis; pat ients frequently have hoarseness, a neck mass, and a distant meta sta sis. Histologically, poorly diffe rentia ted neuroendocrine carci nomas appear much the same as oa t-ce ll tum ors of the lun g. Specimens fea ture small cells, arranged in shee ts or ribbo ns, that contai n hyperchrom at ic nuclei and indistinct nucleoli ; mitosis and necro sis are common." Th ese tum ors frequently metastasize to the bon e, liver, lung and pleura, brain , and adre nal glands.' Th e treatm ent of cho ice for these lesion s is a co mbination of chemotherapy and radiation, but the mean du rati on of survival is less than I year. ' . 206 Moderately differentiated neuroendocri ne carcinomas (atypical carcinoid or large-cell tum ors) are the mo st common subtype (90% of cases). Th ey tend to occur in younge r patients, and they are accomp anied by glossophary ngea l neuralgia. Histologically, these tum ors contain more cytologic atypia, and they fea ture larger cell s, ce llular pleomorphism , and increased mitotic activi ty." Because neuroendocrine markers are usuall y positive, they are a help ful adj unct in makin g the diagnosis. Patients with moderately differenti ated neuro endocrine carcinomas have a poorer progn osis than do patients with well-differentiated neuroend ocrin e carcinom as bec ause the former exhibit a grea ter tend enc y toward local recurre nce and meta static spread. Cut aneou s and subcutaneous spread is seen in 9 to 28 % of cases , which is unu sual." The overall 5-and 10-year survival rates for patients with these tumors ha ve been reported to be 48 and 30 %, res pectively." "J.. Because moderatel y differentiated neuroendocrine carcinomas are radio-and chemoresistant, surgery is the mainstay of treatment. However , conserva tion proc edures should be performed whenever possible , as we did for our patient, because these tumo rs permeate focally rather than throu gh the paraglottic space. Endo scopic resection or supraglottic laryngectomy with prophylactic neck dissections are reliable options for eradicating these tumors .!"!'
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